Zogenix Press News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Zogenix press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Zogenix Press Today - Breaking & Trending Today
Primary endpoint was met demonstrating that FINTEPLA, as adjunctive treatment, is effective in significantly reducing the frequency of drop seizures in LGS. ....
Primary endpoint was met demonstrating that FINTEPLA, as adjunctive treatment, is effective in significantly reducing the frequency of drop seizur. ....
FINTEPLA® has demonstrated efficacy in the most difficult-to-treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle. ....
UCB (Euronext: UCB) today announced the successful completion of the previously announced transaction to acquire Zogenix (NASDAQ: ZGNX) for US$ 26.00 per share plus a milestone-based contingent value right for a potential cash payment of US$ 2.00 per share. The total transaction is valued at up to approximately US . ....
/PRNewswire/ UCB (Euronext: UCB) today announced the successful completion of the previously announced transaction to acquire Zogenix (NASDAQ: ZGNX) for US$. ....